agritech
Commented by Armin Schulz on July 4th, 2026 | 07:00 CEST
Fertilizer Crisis 2026: Why Bayer, MustGrow Biologics, and Yara International Belong on Investors' Watchlists
Created and published on behalf of MustGrow Biologics Corp.
The reopening of the Strait of Hormuz has come too late to prevent disruption. The weeks-long blockade has permanently destabilized the fragile fertilizer markets. During the crucial planting season, European agriculture is plagued by skyrocketing prices and empty warehouses. However, this shock is proving to be an enormous catalyst for a long-overdue change. As conventional chemical and fertilizer solutions face growing economic and regulatory challenges, biological alternatives are increasingly moving from the laboratory to commercial use. This turning point highlights three very different approaches within the global agricultural sector: the embattled industry heavyweight Bayer, the innovative agricultural biotech specialist MustGrow Biologics, and the fertilizer leader Yara International.
Read
Commented by André Will-Laudien on July 1st, 2026 | 06:50 CEST
Here We Go: A Breakthrough for Bayer, Buy Signals for MustGrow and Kraft Heinz
Created and Published on Behalf of MustGrow Biologics Corp.
According to United Nations projections, the world's population is expected to grow to around 9.7 billion people by 2050. The Food and Agriculture Organization (FAO) estimates that this growth can only be managed with significantly more productive and, at the same time, more sustainable farming methods. This is where MustGrow Biologics comes in with biological crop solutions based on natural mustard extracts. And the company's growth story is only just beginning. The sector is gaining short-term momentum now that Bayer has finally received a positive ruling from the US Supreme Court regarding glyphosate. This should allow the Leverkusen-based company's Crop Science division to really take off. At the same time, a powerful structural trend is reshaping the entire agricultural value chain. Natural resources and food must be produced more sustainably and with greater resilience to meet the nutritional needs of a rapidly growing global population. Companies such as Kraft Heinz are responding by leveraging decades of expertise in building resilient agricultural supply chains and climate-adaptive farming systems. These are exciting developments in a sector that is often overlooked in the shadow of high-tech and defence. But the technological trends have long since shifted!
Read
Commented by Matthias Schomber on June 26th, 2026 | 07:25 CEST
SAP Testing the Waters, BYD On the Offensive, and MustGrow Biologics Raises Fresh Capital - Is a Rebound on the Horizon?
Created and published on behalf of MustGrow Biologics Corp.
The winds across global equity markets have grown noticeably stronger, bringing sharp moves in both directions. Technology and automotive giants that have long been accustomed to success are feeling the full force of this turbulence. Faced with declining share prices and geopolitical uncertainty, investors are increasingly looking beyond the mainstream for fresh opportunities. While companies such as SAP and BYD are fighting to defend their lofty valuations, intriguing second-tier players are quietly positioning themselves for growth. This raises a legitimate question: should investors allocate capital into "fallen angels" such as SAP and BYD, or focus on lesser-known growth stories with potentially greater upside? We examine the current market environment and take a closer look at three very different companies. Discover why software heavyweight SAP and electric vehicle pioneer BYD are facing challenges, and why Canadian agtech company MustGrow Biologics could be approaching a breakout. One thing is certain: the stage is set for an exciting summer in the markets.
Read
Commented by Carsten Mainitz on June 25th, 2026 | 07:40 CEST
A Strong Duo in a Huge and Overlooked Growth Market: MustGrow Biologics and Bayer—When Will BayWa Recover?
Created and Published on Behalf of MustGrow Biologics Corp.
Global agriculture is undergoing a profound structural transformation. Climate change—marked by heat waves, droughts, and extreme weather events—is causing billions in crop losses annually in Europe alone. This is driving rising demand for more resilient farming systems and hardier crops. Regenerative agriculture and biological crop protection products are gaining strong momentum, forming the basis of emerging megatrends. According to expert estimates, the market for regenerative agriculture is expected to grow to around USD 50 billion by 2033. This is where the Canadian company MustGrow has positioned itself. Of particular importance is its licensing and development partnership with Bayer for biological crop protection solutions, which creates significant opportunities for this small-cap North American company.
Read
Commented by Nico Popp on June 19th, 2026 | 07:35 CEST
How MustGrow Biologics Benefits from Agrochemical Realignment with Patented Bioactive Technology – Pressure on Bayer and Corteva
Created and published on behalf of MustGrow Biologics Corp.
Extreme heat waves, increasingly degraded soils, and strict regulatory limits on synthetic chemical crop protection products—global agricultural markets are facing a critical period of adjustment. Once temperatures cross the critical threshold of 30 °C, most agricultural crops begin to suffer drastic yield losses, as sterile pollen and weakened cell walls cause irreparable damage to plant biology. According to the joint report by the Food and Agriculture Organization of the United Nations (FAO) and the World Meteorological Organization (WMO) titled "Extreme Heat and Agriculture," even individual heat waves can cause agricultural productivity to plummet by up to 50%. For most major crops, yield losses are already a threat at temperatures as low as 30 °C. The frequency, intensity, and duration of extreme heat events have increased significantly over the past 50 years. These ecological stressors are shifting growing conditions in both temperate and Mediterranean zones, forcing the entire agricultural value chain to rethink its approach.
Read
Commented by André Will-Laudien on June 16th, 2026 | 07:25 CEST
USA–Iran: The Strait of Hormuz is Opening Up! A Sector Buy Signal for Bayer, MustGrow, BASF and K+S!
Created and published on behalf of MustGrow Biologics Corp.
Some things are ultimately not surprising. The "agreement" between the USA–Israel and Iran resembles shadow boxing. One step forward, one step back—that is how the movements at the trading desk appear. The stock markets are reacting accordingly. At the start of the week, optimism about a near-term end to the hostilities is once again dominating. Oil prices are correcting most sharply, down nearly 5%, with Brent now quoted at only USD 82.50 per barrel. This is a positive signal for chemical- and transport-oriented industries in the food sector, with BASF and Bayer showing corresponding strength. Large volumes of goods must be transported globally, and shipping routes carry significant operational importance. As part of efforts to ensure long-term food security, more and more ideas are emerging that could mitigate the international energy crisis. MustGrow focuses on natural ingredients rather than chemicals, while K+S represents a typical example of the "old economy" in this sector. For investors, multiple opportunities for returns are available!
Read
Commented by Armin Schulz on June 11th, 2026 | 06:45 CEST
With Novo Nordisk, MustGrow Biologics, and Bayer: Positioning for Two Megatrends of the Decade
Created and published on behalf of MustGrow Biologics Corp.
Two seemingly opposing crises—obesity and food scarcity—are creating major investment opportunities this year. While the obesity epidemic is placing increasing strain on healthcare systems, climate shocks and geopolitical conflicts are threatening global agricultural yields. The biotech sector is addressing both challenges through biological compounds for weight management and crop protection. Demand for effective obesity treatments and sustainable agricultural solutions is rising rapidly. Investors who position themselves early in the beneficiaries of this dual transformation may benefit from above-average returns. This is precisely where the three companies we are taking a closer look at today are positioned: Novo Nordisk, MustGrow Biologics, and Bayer.
Read
Commented by Tarik Dede on June 9th, 2026 | 08:25 CEST
Agritech Stocks on the Rise: A Look at KWS Saat, MustGrow Biologics, and Bucher Industries!
Created and published on behalf of MustGrow Biologics Corp.
The world's population continues to grow, yet climate change, pesticides, and soil erosion are causing significant challenges to agricultural output. Without agritech companies, it would likely be impossible to feed the world today. At the same time, sustainable farming techniques and crop protection products are in demand; smart farming is a trend, and seeds are also crucial. That is why we are taking a look today at the shares of KWS Saat, MustGrow Biologics, and Bucher Industries.
Read
Commented by Armin Schulz on May 28th, 2026 | 08:30 CEST
Bayer, MustGrow Biologics, K+S: The Secret Formula for Success Behind the Biological Fertilizer Revolution
Created and published on behalf of MustGrow Biologics Corp.
The global fertilizer industry is undergoing its most significant structural transformation in generations. A growing global population, technological breakthroughs in biological agricultural solutions, and policy shifts toward more sustainable agriculture are driving this growth sector. The need for more efficient nutrient use is giving rise to a dynamic market with fresh revenue potential. Companies that pursue the right strategies now are positioning themselves for the coming decade. Three players from different worlds embody this development in their own way: Bayer, MustGrow Biologics, and K+S.
Read
Commented by Nico Popp on May 20th, 2026 | 08:30 CEST
Disruption in the Agricultural Sector: Why Corteva and Deere & Company Are Keeping an Eye on MustGrow Biologics
Created and published on behalf of MustGrow Biologics Corp.
High energy prices, soil degradation, and consumer preference for organic products—the growing pressure on traditional agricultural chemicals poses an existential challenge to established market leaders. Those who do not embrace biological alternatives now risk falling behind due to growing regulatory requirements and increasing resistance. Driven by historically high energy prices, which make the production of conventional fertilizers more expensive, agricultural businesses are facing cost pressures. This economic predicament is becoming a catalyst for innovation: major corporations are investing billions in digital solutions and biologically active ingredients. We shed light on this trend and introduce exciting companies.
Read